Innate Pharma S.A. Statistics
NASDAQ: IPHAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.52-0.07 (-4.40%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Innate Pharma S.A. by the numbers
Innate Pharma S.A. has a market capitalization of $169.8 million based on 111.70M shares outstanding. With trailing EPS of $-0.59, Innate Pharma S.A. is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.8% below its 50-day average and 12.5% below its 200-day average.
Average daily trading volume is 156.58K shares, or about $238,003 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IPHA valuation vs. peer median
| Metric | IPHA | Peer median | Difference |
|---|---|---|---|
| Market cap | $169.78M | $154.55M | +10% |
| Avg. volume | 156.58K | 684.91K | -77% |
Peer median across 8 companies: DTIL, CRDL, CHRS, CMPX, TARA, VYGR, ABOS, MOLN.
Valuation
- Market cap
- $169.78M
- EPS (TTM)
- $-0.59
- Shares outstanding
- 111.70M
Price and trading
- Previous close
- 1.59
- Open
- 1.53
- Day range
- 1.50 – 1.55
- 52-week range
- 1.17 – 2.71
- 52-week change
- -22.05%
- Beta
- —
- Volume
- 13.82K
- Average volume
- 156.58K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 169.78M
- Forward Pe
- -3.22
- Eps
- -0.59
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.71
- Week52 Low
- 1.17
- Avg Volume
- 156.58K
- Shares Outstanding
- 111.70M
- Ma50
- 1.94
- Ma200
- 1.74
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -43.91%
- Pct From52w Low
- 29.91%